Today: 27 April 2026
Centrica share price rises as British Gas owner locks in 10-year gas supply deal
25 February 2026
1 min read

Centrica share price rises as British Gas owner locks in 10-year gas supply deal

London, Feb 25, 2026, 09:26 GMT — Regular session

  • Centrica shares climbed roughly 1.7% soon after the open.
  • The Whitecap agreement kicks in for 2028, tied directly to Europe’s TTF gas benchmark.
  • Centrica’s revised trading outlook and fresh capital returns remain in the investor spotlight.

Centrica shares climbed roughly 1.7% to 194.1 pence as of 0926 GMT, after the owner of British Gas revealed a 10-year natural gas supply deal with Canada’s Whitecap Resources. Deliveries kick off in April 2028. CEO Chris O’Shea described the move as a step toward “a balanced LNG portfolio.” Grant Fagerheim, Whitecap’s chief executive, said it highlights Whitecap’s push to be “a reliable source of energy.” Investing.com

Centrica’s full-year figures dwarf this agreement, but investors are watching for any indication the group might smooth out swings in its LNG trading book—without sacrificing too much potential upside.

The move hands the market a fresh talking point, after last week’s earnings reset. Investors are now weighing whether Centrica’s push into longer-term, more heavily contracted assets might help stabilize a business that’s long been at the mercy of wild gas prices and unpredictable weather.

On Feb. 19, Centrica warned that profit from its Optimisation trading arm was set to fall short of previous forecasts this year. The company temporarily halted its share buyback as annual profit slipped. “Pausing the buyback enables us to prioritise investment,” CEO O’Shea said at the time. JPMorgan analysts noted the revised outlook, combined with transformation costs, could drag near-term estimates lower. Reuters

Whitecap’s deal pegs supply prices to the Title Transfer Facility, or TTF, the main benchmark for European gas. Volumes come in MMBtu—million British thermal units, the industry standard for gas contracts.

Whitecap says its deal with Centrica backs up its push to shift future gas sales away from regional price exposure, linking part of its volumes to premium hubs like TTF.

Centrica’s main concern isn’t really the 2028 volumes—what matters is what this contract suggests. The company is opting to align its LNG exposure with supply that’s pegged to European price swings, avoiding the risk of being overexposed or underexposed to gas when the timing’s off.

Timing looms as the clear risk here. The contract kicks in come April 2028—so forget about any impact on this year’s trading numbers or the ongoing cash flow argument sparked by the buyback freeze.

Investors know “hedging” isn’t a cure-all. Compressed spreads, or when volatility migrates elsewhere on the curve, can still hurt the portfolio—even with tighter matching in place.

Looking ahead, investors now have dates to track: Centrica’s proposed final dividend will need the green light at the AGM set for May 7, with the record date locked in at April 10 and payment penciled in for May 14. That shareholder vote, along with any new detail on capital returns, stands as the next key gauge of sentiment.

Stock Market Today

  • Structure Therapeutics (GPCR) Valuation Falters Amid Share Price Decline
    April 26, 2026, 10:46 PM EDT. Structure Therapeutics (GPCR) shares dropped to $45.49, marking a 49.21% decline over 90 days despite a strong 91.62% one-year total return. The biotech's price-to-book (P/B) ratio of 2.1x appears undervalued versus peers' average of 31.2x and the US pharmaceuticals sector average of 2.6x, suggesting cautious investor sentiment. This ratio compares market value to book value, often used for early-stage or loss-making companies. GPCR faces risks from ongoing clinical trials for GSBR-1290 and significant net losses of $141.2 million. Analyst forecasts predict 56.5% annual revenue growth, but uncertainties linger. Investors should balance potential gains with risks, monitoring clinical outcomes and funding capabilities amid a volatile healthcare sector.

Latest article

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

26 April 2026
SoFi will report first-quarter results before markets open April 29, with management projecting about $1.04 billion in adjusted net revenue and adjusted EPS of 12 cents. Shares closed at $18.44 Friday, valuing the company at $23.8 billion. The company recently launched a digital HELOC and formed a Real Estate Advisory Council. Last quarter, loan originations rose 46% to $10.5 billion and fee-based revenue climbed 53%.
Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom
Previous Story

Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI
Next Story

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI

Go toTop